Nilotinib Hydrochloride Monohydrate
- CAS No.
- 923288-90-8
- Chemical Name:
- Nilotinib Hydrochloride Monohydrate
- Synonyms
- Nilotinib hydrochloride Monohydrate;Nilotinib HCl;Nilotinib HCl Hydrate;Nilotinib Hydrochloride Hydrate;4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}benzamide hydrochloride hydrate;NILOTINIB;TASIGNA;Nilotinib monohydrate;AMN-107;AMN107;TASIGNA;Nilotinib hcl monohydrate;Nilotinib hydrochloride H2O
- CBNumber:
- CB32469912
- Molecular Formula:
- C28H25ClF3N7O2
- Molecular Weight:
- 583.9920096
- MOL File:
- 923288-90-8.mol
- Modify Date:
- 2024/8/2 18:12:07
| Melting point | 198-201°C |
|---|---|
| storage temp. | -20°C Freezer |
| solubility | Aqueous Acid (Slightly), DMSO (Slightly), Ethanol (Slightly, Heated) |
| form | Solid |
| color | Off-White to Pale Beige |
| InChIKey | YCBPQSYLYYBPDW-UHFFFAOYSA-N |
| SMILES | N1(C=C(N=C1)C)C1C=C(C=C(C=1)NC(=O)C1C=CC(=C(NC2=NC=CC(C3=CC=CN=C3)=N2)C=1)C)C(F)(F)F.Cl.O |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319-H335 | |||||||||
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 | |||||||||
| NFPA 704 |
|
Nilotinib Hydrochloride Monohydrate Chemical Properties,Uses,Production
Chemical Properties
Nilotinib hydrochloride monohydrate (NHM) lacks a chiral center, making it incapable of tautomerism. NHM is a chemical compound with the following name: 4-methyl-N-[3-(4-methyl-1H-imidazol1-yl)-5-(trifuoromethyl) phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl) amino] benzamide hydrochloride monohydrate. It is a white powder with a slight yellowish or greenish-yellowish shade. At 25 °C, the aqueous solubility of NHM markedly decreases with pH. Moreover, it is almost insoluble in bufer solutions with pH values higher than 4.5. NHM shows slight solubility in ethanol and methanol. Nilotinib Hydrochloride Monohydrate is the monohydrate monohydrochloride form of nilotinib, an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity.
Uses
Nilotinib Monohydrochloride Monohydrate might be useful in treatment of chronic myelogenous leukemia. It is a COVID19-related research product.
Definition
Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). A Phase I clinical trial in 2006 showed that this drug was relatively safe and offered significant therapeutic benefits in cases of CML which were found to be resistant to treatment with imatinib (Gleevec), another tyrosine kinase inhibitor used as a first-line treatment for CML.
Mechanism of action
Tasigna (nilotinib hydrochloride monohydrate) is an orally available signal transduction inhibitor of the Bcr-Abl kinase, c-kit and Platelet Derived Growth Factor (PDGF). Nilotinib binds to and stabilizes the inactive conformation of the kinase domain of Abl protein. In vitro, nilotinib inhibited Bcr-Abl mediated proliferation of murine leukemic cell lines and human cell lines derived from Ph+ CML patients. In vivo, nilotinib reduced the tumor size in a murine Bcr-Abl xenograft model.
Side effects
a headache, fatigue, gastrointestinal problems such as nausea, vomiting, diarrhea and constipation, muscle and joint pain, rash and other skin conditions, flu-like symptoms, and reduced blood cell count. Less typical side effects are those of the cardiovascular system, such as hypertension (high blood pressure), various types of arrhythmia, and prolonged QT interval. Interaction of nilotinib with OATP1B1 and OATP1B3 may alter its hepatic disposition and can lead to transporter mediated drug-drug interactions.
Nilotinib Hydrochloride Monohydrate Preparation Products And Raw materials
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Brawn Laboratories Limited | +91-01129815331 +91-01129815331 | Haryana, India | 20 | 58 | Inquiry |
| Dr. Reddy's Laboratories Ltd | +91-4049002900 +91-4049002900 | Hyderabad, India | 165 | 58 | Inquiry |
| Basil Drugs AND Pharmaceuticals Pvt Ltd | +91-2249700250 +91-9619320820 | Mumbai, India | 108 | 58 | Inquiry |
| Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
| CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
| Yangzhou Qinyuan Pharmatech Co.,ltd | +86-18752526868 | China | 71 | 58 | Inquiry |
| Biopole Pharmatech Co., Ltd. | +8615151475053 | China | 37 | 58 | Inquiry |
| SICHUAN XIELI PHARMACEUTICAL CO.,LTD. | +86-028-60118998 +8615830127659 | China | 34 | 58 | Inquiry |
| BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | +86-18600796368 +86-18600796368 | China | 123 | 58 | Inquiry |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | China | 21669 | 55 | Inquiry |
Related articles
- Nilotinib Hydrochloride Monohydrate: Chemical Property and Mechanism of action
- Nilotinib Hydrochloride Monohydrate is the monohydrate monohydrochloride form of nilotinib, an orally bioavailable aminopyrimi....
- Mar 28，2024
- Nilotinib hydrochloride monohydrate: pharmacodynamic, pharmacokinetic and tolerability
- Nilotinib hydrochloride monohydrate shows promise as a targeted chronic myeloid leukemia therapy, with complex pharmacokinetic....
- Dec 11，2023
- Side effects of Nilotinib Hydrochloride Monohydrate
- ?Nilotinib (AMN107, trade name Tasigna) has a number of adverse effects typical of anti-cancer drugs: a headache, fatigue, gas....
- Dec 14，2021